Resource
ETMRW - Evidence on the use of endocrine therapy for post-menopausal women metastatic breast cancer
The aim of this review was to compare third generation aromatase inhibitors (AIs) to antioestrogens and progestins in the treatment of post-menopausal women with hormone receptor-positive metastatic breast cancer.
| Filename | etmrw-evidence-use-endocrine-therapy-post-menopausal-metastatic-breast-cancer.pdf |
| Filesize | 1.32 MB |
| Filetype | pdf (Mime Type: application/pdf) |
| Created On: |
01/08/2007 00:00 |
| Last updated on |
29/05/2009 05:37 |